Coherus Biosciences | 販売および管理費





販売および管理費 変化する 日付
AbbVie USD 3.89B 325M 2025-12
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Akebia Therapeutics USD 25.74M 1.93M 2025-03
ALKERMES USD 171.77M 17.9M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amarin USD 17.94M 17.86M 2025-09
Amgen USD 1.94B 237M 2025-12
Baxter International USD 708M 10M 2025-09
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 223.42M 8.86M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Coherus Biosciences USD 26.02M 8.57M 2025-03
Eli Lilly USD 3.13B 391.3M 2025-12
Fujifilm JPY 215.83B 2.93B 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Merck USD 2.85B 215M 2025-12
Myriad Genetics USD 129M 1.3M 2025-09
Pacira USD 91.8M 14.6M 2025-09
Perrigo USD 245.7M 27.4M 2025-09
Pfizer USD 4.08B 894M 2025-12
PTC Therapeutics USD 84.05M 1.22M 2025-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09
Xencor USD 87.78M 72.66M 2025-09
Zoetis USD 579M 29M 2025-09


Coherus Biosciences 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.